We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
+6.4%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$14.8B
AUM Growth
+$1.57B
(+12%)
Cap. Flow
+$949M
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
22.33%
Holding
3,495
New
549
Increased
1,508
Reduced
769
Closed
174
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$106M |
| 2 |
United Rentals
URI
|
+$71.2M |
| 3 |
Fidelity National Information Services
FIS
|
+$51.8M |
| 4 |
NEWR
New Relic, Inc.
NEWR
|
+$47.7M |
| 5 |
DFS
Discover Financial Services
DFS
|
+$42.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$178M |
| 2 |
CHL
China Mobile Limited
CHL
|
+$68.9M |
| 3 |
ACC
American Campus Communities, Inc.
ACC
|
+$54.8M |
| 4 |
Illumina
ILMN
|
+$47.8M |
| 5 |
Progressive
PGR
|
+$43.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.41% |
| 2 | Financials | 15.55% |
| 3 | Healthcare | 12.83% |
| 4 | Consumer Discretionary | 8.8% |
| 5 | Industrials | 7.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Vanguard FTSE Developed Markets ETF
VEA
$235B
| $58.4M | 0.4% |
1,188,820
+286,952
| +32% | +$14M |
|
52
iShares Core S&P 500 ETF
IVV
$903B
| $57.8M | 0.39% |
145,178
-6,073
| -4% | -$2.35M |
|
53
BioMarin Pharmaceuticals
BMRN
$11.7B
| $57.4M | 0.39% |
760,292
-120,044
| -14% | -$9.81M |
|
|
54
Progressive
PGR
$124B
| $57.2M | 0.39% |
598,285
-476,797
| -44% | -$43.3M |
|
55
Alnylam Pharmaceuticals
ALNY
$30.4B
| $56.6M | 0.38% |
400,560
+11,815
| +3% | +$1.78M |
|
56
Merck
MRK
$323B
| $55.9M | 0.38% |
759,437
+62,273
| +9% | +$4.59M |
|
57
Invesco QQQ Trust
QQQ
$484B
| $55.7M | 0.38% |
174,448
+1,486
| +0.9% | +$475K |
|
58
Honeywell
HON
$78.6B
| $55.1M | 0.37% |
269,547
-1,203
| -0.4% | -$235K |
|
59
Trimble
TRMB
$13.8B
| $55.1M | 0.37% |
708,204
-39,996
| -5% | -$2.89M |
|
60
iShares Core MSCI EAFE ETF
IEFA
$194B
| $54.3M | 0.37% |
754,178
+137,133
| +22% | +$9.8M |
|
61
NVIDIA
NVDA
$5.32T
| $53.2M | 0.36% |
3,986,080
+685,920
| +21% | +$9.22M |
|
62
Mastercard
MA
$502B
| $53M | 0.36% |
148,978
-4,955
| -3% | -$1.73M |
|
63
ResMed
RMD
$32.4B
| $52.7M | 0.36% |
271,775
-1,284
| -0.5% | -$257K |
|
64
Nike
NKE
$62.2B
| $51.5M | 0.35% |
387,580
+16,689
| +4% | +$2.32M |
|
65
Comcast
CMCSA
$87.3B
| $51.4M | 0.35% |
950,721
+38,813
| +4% | +$2.05M |
|
66
BridgeBio Pharma
BBIO
$16B
| $50.5M | 0.34% |
819,632
+42,601
| +5% | +$2.79M |
|
67
Oracle
ORCL
$416B
| $50.1M | 0.34% |
713,481
-87,778
| -11% | -$5.68M |
|
68
TSMC
TSM
$2.15T
| $49.4M | 0.33% |
417,633
+96,409
| +30% | +$11.9M |
|
69
McDonald's
MCD
$196B
| $49.1M | 0.33% |
218,960
+12,398
| +6% | +$2.65M |
|
70
Vanguard Information Technology ETF
VGT
$147B
| $49.1M | 0.33% |
1,095,072
-18,600
| -2% | -$837K |
|
71
iShares Russell 1000 Growth ETF
IWF
$128B
| $45M | 0.3% |
741,452
+309,692
| +72% | +$18.8M |
|
72
Omnicell
OMCL
$1.7B
| $44.4M | 0.3% |
342,226
-42,188
| -11% | -$5.41M |
|
73
iShares Russell 1000 Value ETF
IWD
$83.4B
| $44.4M | 0.3% |
293,097
+160,273
| +121% | +$23.2M |
|
|
NEWR
74
DELISTED
New Relic, Inc.
NEWR
| $44.2M | 0.3% |
719,451
+718,351
| +65,305% | +$47.7M |
|
75
Thermo Fisher Scientific
TMO
$213B
| $43.6M | 0.3% |
95,534
+11,006
| +13% | +$5.25M |
|
Similar funds
Rockefeller Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Rockefeller Capital Management held 3,495 positions worth $14.8B, up 12% from $13.2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Rockefeller Capital Management deployed $949M of net new capital in Q1 2021, opening 549 new positions and adding to 1,508 existing holdings. Its largest new stake was iShares Core 80/20 Aggressive Allocation ETF: 369,854 shares worth $24.8M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Verizon, an estimated $178M trimmed.
- Rockefeller Capital Management's largest Q1 2021 buy was iShares Core 80/20 Aggressive Allocation ETF: 369,854 shares worth $24.8M.
- Rockefeller Capital Management added most to Eli Lilly in Q1 2021, an estimated $106M increase.
- Rockefeller Capital Management's biggest Q1 2021 reduction was Verizon, cutting an estimated $178M.
- Rockefeller Capital Management fully exited China Mobile Limited in Q1 2021, selling an estimated $68.9M.
- Rockefeller Capital Management's ten largest holdings make up 22% of its $14.8B portfolio in Q1 2021.
- Rockefeller Capital Management opened 549 new positions and closed 174 in Q1 2021.
- Rockefeller Capital Management's portfolio value rose 12% quarter-over-quarter to $14.8B.
Based on Rockefeller Capital Management's 13F filing for Q1 2021, filed 11 May 2021.